LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 4 of 483
Next
>>
>
76 to 100 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	WZ-4-145	0.04	uM	LJP6	1	J24	72	hr	1334	3295	3970	0.8298	0.7436
BT-20	WZ-4-145	0.04	uM	LJP6	2	J24	72	hr	1334	3081	3970	0.7759	0.6624
BT-20	WZ-4-145	0.04	uM	LJP6	3	J24	72	hr	1334	3552	3970	0.8945	0.8411
BT-20	XMD16-144	0.04	uM	LJP5	1	M12	72	hr	1334	3750	3970	0.9444	0.9162
BT-20	XMD16-144	0.04	uM	LJP5	2	M12	72	hr	1334	3696	3970	0.9308	0.8957
BT-20	XMD16-144	0.04	uM	LJP5	3	M12	72	hr	1334	4028	3970	1.0144	1.0217
BT-20	Brivanib	0.04	uM	LJP5	1	P18	72	hr	1334	4099	3970	1.0323	1.0486
BT-20	Brivanib	0.04	uM	LJP5	2	P18	72	hr	1334	4016	3970	1.0114	1.0171
BT-20	Brivanib	0.04	uM	LJP5	3	P18	72	hr	1334	3909	3970	0.9844	0.9765
BT-20	Buparlisib	0.04	uM	LJP5	1	H06	72	hr	1334	3947	3970	0.9940	0.9909
BT-20	Buparlisib	0.04	uM	LJP5	2	H06	72	hr	1334	4267	3970	1.0746	1.1123
BT-20	Buparlisib	0.04	uM	LJP5	3	H06	72	hr	1334	4236	3970	1.0668	1.1006
BT-20	BX-912	0.04	uM	LJP5	1	L24	72	hr	1334	3650	3970	0.9192	0.8783
BT-20	BX-912	0.04	uM	LJP5	2	L24	72	hr	1334	3603	3970	0.9074	0.8604
BT-20	BX-912	0.04	uM	LJP5	3	L24	72	hr	1334	3965	3970	0.9985	0.9978
BT-20	Canertinib	0.04	uM	LJP6	1	H12	72	hr	1334	3138	3970	0.7903	0.6841
BT-20	Canertinib	0.04	uM	LJP6	2	H12	72	hr	1334	3769	3970	0.9492	0.9234
BT-20	Canertinib	0.04	uM	LJP6	3	H12	72	hr	1334	3577	3970	0.9008	0.8506
BT-20	Celastrol	0.04	uM	LJP6	1	G12	72	hr	1334	3944	3970	0.9932	0.9898
BT-20	Celastrol	0.04	uM	LJP6	2	G12	72	hr	1334	4087	3970	1.0292	1.0440
BT-20	Celastrol	0.04	uM	LJP6	3	G12	72	hr	1334	4039	3970	1.0171	1.0258
BT-20	CGP60474	0.04	uM	LJP5	1	F06	72	hr	1334	3460	3970	0.8713	0.8062
BT-20	CGP60474	0.04	uM	LJP5	2	F06	72	hr	1334	3509	3970	0.8837	0.8248
BT-20	CGP60474	0.04	uM	LJP5	3	F06	72	hr	1334	3622	3970	0.9121	0.8677
BT-20	CGP60474	0.04	uM	LJP6	1	G06	72	hr	1334	810	3970	0.2040	-0.1990

|<
<<
Previous
Page 4 of 483
Next
>>
>
76 to 100 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)